Cases & Deals

Bay City Capital fund invests in Via Pharmaceuticals

Clients Bay City Capital Fund IV

Jones Day represented Bay City Capital Fund IV in connection with its purchase of $10 million of Notes and Warrants and concurrent secured bridge loan to Via Pharmaceuticals, Inc., a biotechnology company focused on the development of compounds for the treatment of cardiovascular and metabolic disease.